Scarica l'app Stockscreener
17.03
3.51%
-0.62
Pre-mercato:
16.85
-0.18
-1.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVCR Giù?
Forum
Previsione
Novocure Ltd Borsa (NVCR) Ultime notizie
Novocure Ltd (NVCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Novocure Posts Record Q2 Revenue of US$183.6M - Streetwise Reports
NovoCure (NVCR) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
NovoCure Market Sentiment - Benzinga España
Wall Street Analysts Believe NovoCure (NVCR) Could Rally 46.63%: Here's is How to Trade - Yahoo Finance Singapore
Novocure Ltd (NVCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NovoCure Ltd. (NVCRN) Q1 2023 Earnings ReportResults, Call & Slides - TipRanks
NovoCure (NVCR) Is Up 10.9% After Raising 2026 Revenue Outlook and Securing New CE Mark Approval – Has The Bull Case Changed? - simplywall.st
NovoCure Ltd. Revenue Breakdown – FWB:038 - TradingView
NovoCure Ltd. Revenue Breakdown – LSX:A140ML - TradingView
NovoCure Ltd. (NVCRN) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
NovoCure (NVCR) Lifts 2026 Guidance After Record Quarter While Fair Value Debate Builds - Yahoo Finance UK
TradingKey - TradingKey
Novocure Ltd (NVCR) Cash Flow - TradingKey
NovoCure (NVCR) Stock Faces Ongoing Losses As Q2 2026 EPS Narrows To $0.13 Loss - simplywall.st
Novocure Ltd (NVCR) Institutional Confidence - TradingKey
NVCR Maintained by Wedbush -- Price Target Raised to $20.00 - GuruFocus
H.C. Wainwright cuts NovoCure stock price target to $32 on valuation - Investing.com UK
Novocure Is Maintained at Neutral by Wedbush - Moomoo
NovoCure Posts Record Revenue and Raises Guidance, But NVCR Stock Tumbles Over 6% - finance.biggo.com
NovoCure's Strongest Quarter Ever Isn't Enough to Stop NVCR Stock From Sliding - Benzinga
Form 144 NovoCure Limited For: 24 July By Investing.com - Investing.com Nigeria
NovoCure Q2 2026 slides: profitability in sight, guidance raised By Investing.com - Investing.com Nigeria
Novocure Ltd (NVCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Novocure Ltd earnings beat by $0.20, revenue topped estimates - Investing.com Nigeria
Novocure Cash, Cash Equivalents and Short-Term Investments Were $440.6M as of June 30 >NVCR - Moomoo
NovoCure (NVCR) Breaks Out on Q2 2026 EarningsOptune Pax Driving Recovery - TradingKey
Novocure (NVCR) Hits New High on Optimistic Outlook, FDA Approval Hopes - Yahoo Finance
NVCR Maintained by HC Wainwright & Co. -- Price Target Raised to $52 - GuruFocus
Earnings call transcript: NovoCure beats Q2 2026 forecasts, shares jump 16% - Investing.com Nigeria
NovoCure Ltd SEC Filing (Jul 23, 2026) - Stock Titan
NVCR Stock Surges 28% For Best Day In Over 1.5 Years — What’s Driving The Rally? - Yahoo Finance
NovoCure Ltd (NVCR) Q2 2026 Earnings Call Highlights: Record Rev - GuruFocus
NovoCure Ltd (NVCR) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance
NovoCure's Q2 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Raised - Moomoo
NovoCure Shares Surge 29% on Q2 Results, 2026 Forecast Raised - TechStock²
Crude Oil Rises Sharply; T-Mobile Shares Fall Following Q2 Results - Benzinga
Is Novocure Ltd (NVCR) Positioned for Growth After Q2 Earnings? - GuruFocus
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Top U.S. trending stocks: NovoCure leads with 23.4% surge - Investing.com
NovoCure surges on Q2 resultsGlobes - Globes - Israel Business News
Novocure stock hits 52-week high at 19.49 USD By Investing.com - Investing.com Nigeria
NovoCure Ltd Q2 2026 Financial Results: Revenue, R&D, and Key Risks Highlighted in Latest 10-Q Filing - Minichart
Novocure Reports Record Second-Quarter Revenue as Optune Expansion Drives Higher 2026 Outlook - Yahoo Finance
Earnings call transcript: NovoCure beats Q2 2026 forecasts, shares jump 16% By Investing.com - Investing.com South Africa
Novocure stock hits 52-week high at 19.49 USD - Investing.com
Novocure Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
NovoCure Q2 2026 slides: profitability in sight, guidance raised - Investing.com
Transcript: NovoCure Q2 2026 Earnings Conference Call - Benzinga
NovoCure Q2 Earnings Call Highlights - Yahoo Finance
NovoCure (NVCR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Q2 2026 Novocure Ltd Earnings Call Transcript - GuruFocus
NOVOCURE ($NVCR) Releases Q2 2026 Earnings - Quiver Quantitative
NovoCure: Q2 Earnings Snapshot - Yahoo Finance
NovoCure (NASDAQ: NVCR) lifts Q2 revenue 16% to $183.6M amid new approvals - Stock Titan
Novocure Reports Second Quarter 2026 Financial Results - Yahoo Finance
NVCR|Novocure Ltd|Price:18.819|Chg%:-1.171 - TradingKey
0.79%
4.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):